Septicemia is life a threatening infection where bacteria enters into the bloodstream. It is also called bacteremia or blood poisoning. Septicemia can emerge from any kind of infections throughout the body such as infections in abdomen, lungs and urinary tract. Septicemia may or may not get associated with the infections of heart, central nervous system, bone and other tissues. Septicemia can quickly become life-threatening. If it is left untreated, septicemia can progress to sepsis. Sepsis is when inflammation throughout the body occurs. This inflammation can cause blood clots and block oxygen from reaching vital organs, resulting in organ failure. When information occurs with extremely low blood pressure, it is called septic shock. Other than these, patients suffering from septicemia complain about rapid breathing, chills and rapid heartbeat.
Septicemia leads to infections like urinary tract infections, lung infections, kidney infections and infections in the abdominal area.
Septicemia Diagnostic Testing Market: Drivers and Restraints
Septicemia is often confirmed by a blood test. But a blood test may not reveal infection in patients who have been taking antibiotics. This is the main driving force for septicemia diagnostic testing market. Increasing incidence of septicemia and its life-threatening risk are responsible for the growth of this market. However, lack of awareness among the people about the disease and the huge costs involved in the treatment of septicemia are restraining the septicemia diagnostic testing market to grow.
Request for sample report: http://www.futuremarketinsights.com/reports/sample/rep-gb-1491
Septicemia Diagnostic Testing Market: Segmentation
Septicemia Diagnostic testing market can be segmented on the basis of test type, end use and geography.
Based on test type, septicemia diagnostic testing market can be segmented as follows:
- Laboratory tests
- Blood culture
- Complete B Count
- Clotting studies
- Prothrombin time(PT)
- Partial thromboplastin time(PTT)
- Fibrinogen levels
- Cerebrospinal fluid (CSF)culture
- Culture of skin sore
- Platelet count
- Urine culture
- Imaging tests
- CT scan
Based on end use, septicemia diagnostic testing market can be segmented as follows:
- Diagnostic laboratories
- Academic and Medical Institutes
- Contract Research Organization
- Hospital laboratories
Septicemia Diagnostic Testing Market: Overview
For diagnosing septicemia, doctors first undergo the medical history for patient for confirming any kind of bacterial infection in the past and then, perform all the tests accordingly. Again, if the site of the infection is not obvious then the doctor might order one or more imaging tests. The global septicemia diagnostic testing market is expected to undergo technological innovation in the future, thus generating positive market opportunities for new product introductions.
Request for TOC: http://www.futuremarketinsights.com/toc/rep-gb-1491
Septicemia Diagnostic Testing Market: Region-wise Outlook
Region wise, the global septicemia diagnostic testing marketis classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Septicemia diagnostic testing markets have already reached maturity stage for European countries. The North and South American markets are also generating impressive revenue from septicemia diagnostic testing while Asia-Pacific market is at growth stage. Industrialized regions are more prone to septicemia giving American and European markets a head over Asia-Pacific market.
Septicemia Diagnostic Testing Market: Key Players
Key players contributing to septicemia diagnostic testing market are Becton, Dickinson and Company, BioMérieux, TREK Diagnostic Systems, Hoffmann-La Roche Ltd, Molzym GmbH & Co., AM–Pharma, Spectral Medical Inc. and Thermo Fisher Scientific amongst others.